Is teicoplanin a complementary treatment option for COVID-19? The question remains

Detalles Bibliográficos
Autores principales: Ceccarelli, Giancarlo, Alessandri, Francesco, d'Ettorre, Gabriella, Borrazzo, Cristian, Spagnolello, Ornella, Oliva, Alessandra, Ruberto, Franco, Mastroianni, Claudio M., Pugliese, Francesco, Venditti, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. and International Society of Chemotherapy. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245324/
https://www.ncbi.nlm.nih.gov/pubmed/32454071
http://dx.doi.org/10.1016/j.ijantimicag.2020.106029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245324/
https://www.ncbi.nlm.nih.gov/pubmed/32454071
http://dx.doi.org/10.1016/j.ijantimicag.2020.106029

Ejemplares similares